Boston Scientific Corp
BSX- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000885725
In the last 90 days, Boston Scientific Corp insiders filed 5 open-market purchases and 0 sales; 1,486 institutions reported holding it in 13F filings for Q2 2026, worth $57.3B in total; Maverick Capital is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Boston Scientific Corp changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 1,693 | 27 | 1,714 | +48 |
| Shares | 1.35B | 20.8M | 1.34B | +10.1M (+0.8%) |
| Value | $145.4B | $2.24B | $131.1B | −$12.0B (−8.4%) |
27 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (179)
Institutions that held Boston Scientific Corp at the end of Q3 2025 but not at the end of Q2 2025.
Showing the largest 100 of 179 by value.
Sold out (131)
Institutions that held Boston Scientific Corp at the end of Q2 2025 and filed for Q3 2025 without it.
Showing the largest 100 of 131 by value.
Not filed for Q3 2025 yet (27)
Institutions that held Boston Scientific Corp at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.